Methylene blue has been shown to shrink tumors and slow cancer growth by targeting cancer cell metabolism and energy production
Photodynamic therapy with methylene blue uses light activation to destroy cancer cells while leaving healthy cells unharmed, making it a more precise treatment option
Research on ovarian cancer found that methylene blue forces tumors to shift away from their preferred energy source, making them more vulnerable to treatment
Unlike chemotherapy, methylene blue treatment does not cause significant side effects or toxicity, making it a promising option for patients with drug-resistant cancers
Proper dosing is important. Just 5 milligrams of pharmaceutical-grade methylene blue per day is enough to reduce cellular stress and support mitochondrial health
